Health • March 27, 2026
New Drug Could Change Lives of Kids with Resistant Epilepsy, Patient Trials Concluded
Originally published on Good News Network
A phase 2 clinical trial in England has demonstrated smashing success in improving the conditions of children with a rare form of treatment-resistant epilepsy called Dravet syndrome. Believed to affect 3,000 children in England, it's just one out of hundreds of forms of genetic epilepsy that have no pharmacological options. Scientists not involved with the Good News Network .
A phase 2 clinical trial in England has demonstrated smashing success in improving the conditions of children with a rare form of treatment-resistant epilepsy called Dravet syndrome. Believed to affect 3,000 children in England, it's just one out of hundreds of forms of genetic epilepsy that have no pharmacological options. Scientists not involved with the Good News Network .
Originally published on Good News Network.
More good news
- Amid Spokane fires, local bootmaker turns headquarters into refuge for firefighters, distributes new shoes for free
- Town’s Beloved Santa Claus Delivers a Very Special Present to Someone in Need–His Donated Kidney
- That time you learn you've been lying to yourself.
- Man recreates a 30 years photo of him and his dad, with his son